Journal
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
Volume 34, Issue 4, Pages 749-753Publisher
WILEY
DOI: 10.1111/j.1447-0756.2008.00919.x
Keywords
immunochemotherapy; primary non-Hodgkin's lymphoma; rituximab; uterine body
Categories
Ask authors/readers for more resources
Primary malignant lymphoma of the female genital tract is extremely rare and no standard treatment has been established. The present patient is menopausal with diffuse large B-cell lymphoma of the uterine body, endocervix and parametrium. She underwent a simple total abdominal hysterectomy and bilateral salpingo-oophorectomy, followed by treatment with a new regimen, combined immunochemotherapy with rituximab (monoclonal antibody), cyclophosphamide vincristine, and prednisolone. The patient had complete remission in the follow-up 3 years after this therapy. We suggest this treatment is a useful therapy for a patient with primary malignant lymphoma of the uterine body.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available